154.61
前日終値:
$154.10
開ける:
$155.01
24時間の取引高:
1.67M
Relative Volume:
0.73
時価総額:
$27.64B
収益:
$15.50B
当期純損益:
$1.33B
株価収益率:
21.06
EPS:
7.34
ネットキャッシュフロー:
$2.16B
1週間 パフォーマンス:
-2.66%
1か月 パフォーマンス:
+8.26%
6か月 パフォーマンス:
-19.04%
1年 パフォーマンス:
-27.36%
Iqvia Holdings Inc Stock (IQV) Company Profile
IQV を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
IQV
Iqvia Holdings Inc
|
154.61 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
![]()
TMO
Thermo Fisher Scientific Inc
|
392.56 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
194.44 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
519.85 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
115.52 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-04-25 | ダウングレード | HSBC Securities | Buy → Hold |
2025-04-10 | ダウングレード | Barclays | Overweight → Equal Weight |
2025-02-03 | ダウングレード | BTIG Research | Buy → Neutral |
2024-12-20 | 開始されました | Stephens | Overweight |
2024-10-14 | 開始されました | Redburn Atlantic | Buy |
2024-09-04 | 開始されました | RBC Capital Mkts | Outperform |
2024-07-24 | ダウングレード | Jefferies | Buy → Hold |
2024-06-06 | 開始されました | Goldman | Buy |
2024-02-26 | 開始されました | Leerink Partners | Outperform |
2024-02-15 | ダウングレード | Guggenheim | Buy → Neutral |
2024-02-13 | 開始されました | BTIG Research | Buy |
2023-11-02 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2023-09-06 | 開始されました | HSBC Securities | Buy |
2023-03-17 | 開始されました | Truist | Buy |
2022-12-06 | 開始されました | Cowen | Outperform |
2022-11-17 | ダウングレード | Citigroup | Buy → Neutral |
2022-08-25 | 開始されました | Credit Suisse | Outperform |
2022-07-15 | 開始されました | SVB Leerink | Outperform |
2022-05-24 | 開始されました | Guggenheim | Buy |
2022-04-29 | アップグレード | Piper Sandler | Neutral → Overweight |
2022-04-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2021-08-05 | 再開されました | Credit Suisse | Outperform |
2021-04-16 | アップグレード | Stephens | Equal-Weight → Overweight |
2021-03-08 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
2021-03-03 | 開始されました | Barclays | Overweight |
2020-07-07 | 開始されました | Stephens | Equal-Weight |
2020-03-02 | 開始されました | Deutsche Bank | Buy |
2020-01-08 | 開始されました | Wells Fargo | Overweight |
2020-01-07 | 開始されました | Citigroup | Buy |
2019-12-13 | アップグレード | CFRA | Sell → Hold |
2019-11-14 | アップグレード | Wolfe Research | Peer Perform → Outperform |
2019-06-21 | アップグレード | Mizuho | Neutral → Buy |
2019-05-28 | 開始されました | SVB Leerink | Outperform |
2019-01-18 | アップグレード | Jefferies | Hold → Buy |
2018-10-09 | 開始されました | UBS | Buy |
2018-10-02 | 繰り返されました | Robert W. Baird | Outperform |
2018-07-25 | アップグレード | BofA/Merrill | Neutral → Buy |
2018-07-25 | 繰り返されました | Stifel | Buy |
2018-07-03 | アップグレード | Raymond James | Outperform → Strong Buy |
2018-04-13 | アップグレード | Goldman | Neutral → Buy |
2018-03-07 | アップグレード | SunTrust | Hold → Buy |
2018-01-19 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Iqvia Holdings Inc (IQV) 最新ニュース
Baird Adjusts Price Target on IQVIA Holdings to $159 From $161, Maintains Neutral Rating - MarketScreener
Drug Development Inputs & Services Stocks Q1 Highlights: IQVIA (NYSE:IQV) - Yahoo Finance
IQVIA Holdings Stock: Is IQV Underperforming the Healthcare Sector? - MSN
IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement’ - Business Wire
Learn to Evaluate (IQV) using the Charts - news.stocktradersdaily.com
Park Avenue Securities LLC Grows Stock Position in IQVIA Holdings Inc. (NYSE:IQV) - Defense World
IQVIA Completes $2 Billion Senior Notes Offering - Global Legal Chronicle
Nvidia Just Partnered With A Weight-Loss Giant, But It's Not About Pills - Benzinga
IQVIA unveils AI agents for life sciences using NVIDIA technology By Investing.com - Investing.com South Africa
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MSN
IQVIA Launches New AI Agents for Life Sciences and Healthcare - MarketScreener
IQVIA unveils AI agents for life sciences using NVIDIA technology - Investing.com
IQVIA Holdings Stock: Is IQV Underperforming The Healthcare Sector? - Barchart.com
IQVIA Stock: Stuck In A Time SpiralValue Play Or Bull Trap? - Benzinga
IQVIA Holdings (NYSE:IQV) Sees 11% Share Price Rise Over Last Week - Yahoo Finance
IQVIA Holdings Inc (IQV) Trading 3.9% Higher on Jun 10 - GuruFocus
IQVIA Holdings (IQV) Leads S&P 500 Healthcare Gainers - GuruFocus
IQVIA Holdings Issues $2 Billion in Senior Notes - TipRanks
IQVIA Holdings Inc (IQV) Trading 3.85% Higher on Jun 4 - GuruFocus
IQVIA to raise $2B via senior notes offering to repay debt - MSN
IQVIA announces pricing of senior notes - MSN
IQVIA prices $2 billion senior notes offering By Investing.com - Investing.com South Africa
IQVIA Holdings Inc. (IQV) Announces $2 Billion Senior Notes Offe - GuruFocus
Rep. Robert Bresnahan, Jr. Sells Off Shares of IQVIA Holdings Inc. (NYSE:IQV) - Defense World
IQVIA Announces Pricing of Senior Notes - 01net
IQVIA Inc. (IQV) Secures $2 Billion in Senior Notes Offering - GuruFocus
IQVIA Holdings Announces $2 Billion Senior Notes Offering - TipRanks
IQVIA Announces Pricing of Senior Notes | IQV Stock News - GuruFocus
IQVIA Prices $2 Billion Senior Notes Due 2032 - marketscreener.com
IQVIA Announces Pricing Of Senior Notes - marketscreener.com
IQVIA prices $2 billion senior notes offering - Investing.com Australia
IQVIA announces offering of senior notes - IQVIA
IQVIA Announces Offering of Senior Notes - BioSpace
Iqvia Plans $2 Billion Notes Offering - marketscreener.com
IQVIA Announces Offering of Senior Notes | IQV Stock News - GuruFocus
IQVIA plans $2 billion senior notes offering by 2032 - Investing.com
Iqvia Announces Offering Of Senior Notes - marketscreener.com
IQVIA Holdings Inc. (NYSE:IQV) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
What is Zacks Research’s Forecast for IQVIA Q2 Earnings? - Defense World
IQVIA Holdings Inc (IQV) Trading 3.28% Higher on May 27 - GuruFocus
IQVIA Holdings Inc. Announces First Patient Dosed in Renew Phase 2 Trial of Lti-03 in Patients with Ipf - marketscreener.com
IQV Collaborates with Rein Therapeutics on New IPF Trial | IQV S - GuruFocus
IQV Collaborates with Rein Therapeutics on New IPF Trial | IQV Stock News - GuruFocus
Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF - marketscreener.com
Iqvia Holdings Inc (IQV) 財務データ
収益
当期純利益
現金流量
EPS
Iqvia Holdings Inc (IQV) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
DANHAKL JOHN G | Director |
Dec 03 '24 |
Buy |
200.58 |
1,275 |
255,740 |
1,275 |
Sherbet Eric | See Remarks |
Aug 27 '24 |
Sale |
246.33 |
1,300 |
320,229 |
19,536 |
大文字化:
|
ボリューム (24 時間):